Enlivex Therapeutics Ltd. (ENLV)

NASDAQ: ENLV · Real-Time Price · USD

1.210

+0.050 (4.31%)

At close: Dec 5, 2025, 4:00 PM EST

1.180

-0.030 (-2.48%)

After-hours: Dec 5, 2025, 7:54 PM EST

Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of $29.39 million as of December 5, 2025. Its market cap has increased by 29.78% in one year.

Market Cap

29.39M

Enterprise Value

11.89M

1-Year Change

29.78%

Ranking

#4825

Market Cap Chart

Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from $101.63M to $29.39M, a decrease of -71.08%. That is a compound annual growth rate of -16.90%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	29.39M	14.25%
Dec 31, 2024	25.73M	-48.77%
Dec 29, 2023	50.22M	-30.73%
Dec 30, 2022	72.50M	-36.72%
Dec 31, 2021	114.57M	-5.58%
Dec 31, 2020	121.34M	39.92%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	904.62B
Johnson & Johnson	486.51B
AbbVie	399.57B
UnitedHealth Group	299.75B
AstraZeneca	280.82B
Novartis AG	255.15B
Merck & Co.	247.51B
Abbott Laboratories	217.50B

Market Cap Rankings